Metropolitan Life Insurance Company (MetLife)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,087
Closed -$51.2K 260
2024
Q1
$51.2K Sell
10,087
-1,545
-13% -$7.85K ﹤0.01% 1395
2023
Q4
$69.7K Hold
11,632
﹤0.01% 1271
2023
Q3
$82.4K Buy
11,632
+1,604
+16% +$11.4K ﹤0.01% 1121
2023
Q2
$70.6K Hold
10,028
﹤0.01% 1214
2023
Q1
$83.6K Sell
10,028
-1,438
-13% -$12K ﹤0.01% 1098
2022
Q4
$132K Buy
11,466
+364
+3% +$4.18K 0.01% 917
2022
Q3
$140K Hold
11,102
0.01% 829
2022
Q2
$117K Hold
11,102
0.01% 969
2022
Q1
$181K Sell
11,102
-36,266
-77% -$590K 0.01% 867
2021
Q4
$656K Hold
47,368
0.01% 1244
2021
Q3
$681K Sell
47,368
-4,706
-9% -$67.6K 0.01% 1237
2021
Q2
$823K Buy
52,074
+4,089
+9% +$64.6K 0.01% 1158
2021
Q1
$488K Sell
47,985
-3,484
-7% -$35.4K 0.01% 1425
2020
Q4
$383K Sell
51,469
-2,325
-4% -$17.3K 0.01% 1538
2020
Q3
$185K Buy
53,794
+3,105
+6% +$10.7K ﹤0.01% 1819
2020
Q2
$242K Sell
50,689
-1
-0% -$5 ﹤0.01% 1680
2020
Q1
$101K Buy
50,690
+313
+0.6% +$626 ﹤0.01% 2022
2019
Q4
$174K Buy
50,377
+13,406
+36% +$46.3K ﹤0.01% 2020
2019
Q3
$106K Hold
36,971
﹤0.01% 2273
2019
Q2
$140K Hold
36,971
﹤0.01% 2129
2019
Q1
$301K Hold
36,971
0.01% 1636
2018
Q4
$298K Buy
36,971
+1,067
+3% +$8.61K 0.01% 1551
2018
Q3
$274K Buy
35,904
+4,590
+15% +$35K ﹤0.01% 1786
2018
Q2
$179K Hold
31,314
﹤0.01% 2013
2018
Q1
$149K Buy
31,314
+4,491
+17% +$21.4K ﹤0.01% 2078
2017
Q4
$132K Sell
26,823
-33,253
-55% -$164K ﹤0.01% 2151
2017
Q3
$315K Sell
60,076
-50
-0.1% -$262 ﹤0.01% 2001
2017
Q2
$334K Hold
60,126
﹤0.01% 1986
2017
Q1
$505K Buy
60,126
+3,339
+6% +$28K ﹤0.01% 1648
2016
Q4
$359K Sell
56,787
-4,399
-7% -$27.8K ﹤0.01% 1956
2016
Q3
$270K Sell
61,186
-2,330
-4% -$10.3K ﹤0.01% 2138
2016
Q2
$180K Buy
+63,516
New +$180K ﹤0.01% 2388
2016
Q1
Sell
-52,196
Closed -$539K 2508
2015
Q4
$539K Hold
52,196
﹤0.01% 1578
2015
Q3
$595K Hold
52,196
﹤0.01% 1524
2015
Q2
$779K Buy
+52,196
New +$779K 0.01% 1450
2015
Q1
Sell
-54,718
Closed -$665K 2234
2014
Q4
$665K Hold
54,718
﹤0.01% 1568
2014
Q3
$535K Hold
54,718
﹤0.01% 1674
2014
Q2
$698K Buy
+54,718
New +$698K ﹤0.01% 1591